These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33856508)

  • 21. Assessment of free-hand transperineal targeted prostate biopsy using multiparametric magnetic resonance imaging-transrectal ultrasound fusion in Chinese men with prior negative biopsy and elevated prostate-specific antigen.
    Lian H; Zhuang J; Wang W; Zhang B; Shi J; Li D; Fu Y; Jiang X; Zhou W; Guo H
    BMC Urol; 2017 Jul; 17(1):52. PubMed ID: 28679370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostate cancer detection using magnetic resonance imaging-transrectal ultrasound fusion biopsy: A retrospective cohort study.
    Pratihar SK; Khanna A; Vasudeo V; Gupta R; Saurabh N; Kumar B; Ali M; Akotkar SS; Rawal SK; Singh A
    Indian J Urol; 2023; 39(4):297-302. PubMed ID: 38077193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of targeted biopsy guided by elastic image fusion of MRI with 3D-TRUS on diagnosis of anterior prostate cancer.
    Baco E; Rud E; Ukimura O; Vlatkovic L; Svindland A; Matsugasumi T; Bernhard JC; Rewcastle JC; Eggesbø HB
    Urol Oncol; 2014 Nov; 32(8):1300-7. PubMed ID: 25189687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Further reduction of disqualification rates by additional MRI-targeted biopsy with transperineal saturation biopsy compared with standard 12-core systematic biopsies for the selection of prostate cancer patients for active surveillance.
    Radtke JP; Kuru TH; Bonekamp D; Freitag MT; Wolf MB; Alt CD; Hatiboglu G; Boxler S; Pahernik S; Roth W; Roethke MC; Schlemmer HP; Hohenfellner M; Hadaschik BA
    Prostate Cancer Prostatic Dis; 2016 Sep; 19(3):283-91. PubMed ID: 27184812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison between "In-bore" MRI guided prostate biopsy and standard ultrasound guided biopsy in the patient with suspicious prostate cancer: Preliminary results.
    D'Agostino D; Mineo Bianchi F; Romagnoli D; Corsi P; Giampaoli M; Schiavina R; Brunocilla E; Artibani W; Porreca A
    Arch Ital Urol Androl; 2019 Jul; 91(2):. PubMed ID: 31266272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is targeted magnetic resonance imaging/transrectal ultrasound fusion prostate biopsy enough for the detection of prostate cancer in patients with PI-RADS ≥3: Results of a prospective, randomized clinical trial.
    Zhang J; Zhu A; Sun D; Guo S; Zhang H; Liu S; Fu Q; Zhang K
    J Cancer Res Ther; 2020; 16(7):1698-1702. PubMed ID: 33565519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First round of targeted biopsies using magnetic resonance imaging/ultrasonography fusion compared with conventional transrectal ultrasonography-guided biopsies for the diagnosis of localised prostate cancer.
    Mozer P; Rouprêt M; Le Cossec C; Granger B; Comperat E; de Gorski A; Cussenot O; Renard-Penna R
    BJU Int; 2015 Jan; 115(1):50-7. PubMed ID: 24552477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of PIRADS 3 lesions with histopathological findings after MRI-fusion targeted biopsy of the prostate in a real world-setting.
    Schlenker B; Apfelbeck M; Armbruster M; Chaloupka M; Stief CG; Clevert DA
    Clin Hemorheol Microcirc; 2019; 71(2):165-170. PubMed ID: 30562897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective randomized trial comparing magnetic resonance imaging (MRI)-guided in-bore biopsy to MRI-ultrasound fusion and transrectal ultrasound-guided prostate biopsy in patients with prior negative biopsies.
    Arsov C; Rabenalt R; Blondin D; Quentin M; Hiester A; Godehardt E; Gabbert HE; Becker N; Antoch G; Albers P; Schimmöller L
    Eur Urol; 2015 Oct; 68(4):713-20. PubMed ID: 26116294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer Detection Rates in Targeted Transperineal MRI-TRUS Elastic Fusion-guided Prostate Biopsies Performed Under Local Anesthesia.
    Jacewicz M; Rud E; Galtung KF; Noor D; Baco E
    Anticancer Res; 2021 Sep; 41(9):4395-4400. PubMed ID: 34475059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can combined multiparametric magnetic resonance imaging of the prostate and prostate-specific antigen density improve the detection of clinically significant prostate cancer: A prospective single-center cross-sectional study.
    Yadav K; Sureka B; Elhence P; Choudhary GR; Pandey H; Garg PK; Yadav T; Khera PS
    J Cancer Res Ther; 2021; 17(2):372-378. PubMed ID: 34121679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic Value of Cognitive-Registration Multiparametric Magnetic Resonance Guided Biopsy for the Detection of Prostate Cancer after Initial Negative Biopsy.
    Tomašković I; Pezelj I; Bolanča Čulo K; Novosel L; Nikles S; Tomić M; Reljić A; Katušić J; Knežević M; Pirša M; Kruslin B; Ulamec M; Ružić B
    Acta Clin Croat; 2018 Oct; 57(Suppl 1):40-45. PubMed ID: 30457246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of Prostate Cancer in PI-RADS Version 2.1 Transition Zone Atypical Nodules Upgraded by Abnormal DWI: Correlation With MRI-Directed TRUS-Guided Targeted Biopsy.
    Lim CS; Abreu-Gomez J; Carrion I; Schieda N
    AJR Am J Roentgenol; 2021 Mar; 216(3):683-690. PubMed ID: 32755208
    [No Abstract]   [Full Text] [Related]  

  • 34. The detection of significant prostate cancer is correlated with the Prostate Imaging Reporting and Data System (PI-RADS) in MRI/transrectal ultrasound fusion biopsy.
    Cash H; Maxeiner A; Stephan C; Fischer T; Durmus T; Holzmann J; Asbach P; Haas M; Hinz S; Neymeyer J; Miller K; Günzel K; Kempkensteffen C
    World J Urol; 2016 Apr; 34(4):525-32. PubMed ID: 26293117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "In-bore" MRI-guided Prostate Biopsy Using an Endorectal Nonmagnetic Device: A Prospective Study of 70 Consecutive Patients.
    Schiavina R; Vagnoni V; D'Agostino D; Borghesi M; Salvaggio A; Giampaoli M; Pultrone CV; Saraceni G; Gaudiano C; Vigo M; Bianchi L; Dababneh H; La Manna G; Chessa F; Romagnoli D; Martorana G; Brunocilla E; Porreca A
    Clin Genitourin Cancer; 2017 Jun; 15(3):417-427. PubMed ID: 28258961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early experience with multiparametric magnetic resonance imaging-targeted biopsies under visual transrectal ultrasound guidance in patients suspicious for prostate cancer undergoing repeated biopsy.
    Boesen L; Noergaard N; Chabanova E; Logager V; Balslev I; Mikines K; Thomsen HS
    Scand J Urol; 2015 Feb; 49(1):25-34. PubMed ID: 24922550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Performance of Combined Magnetic Resonance Imaging/Ultrasound Fusion-guided and Systematic Biopsy of the Prostate in Biopsy-naïve Patients and Patients with Prior Biopsies.
    Preisser F; Theissen L; Wenzel M; Humke C; Bodelle B; Köllermann J; Kluth L; Banek S; Becker A; Roos F; Chun FK; Mandel P
    Eur Urol Focus; 2021 Jan; 7(1):39-46. PubMed ID: 31296485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostate cancer treatment by the latest focal HIFU device with MRI/TRUS-fusion control biopsies: A prospective evaluation.
    von Hardenberg J; Westhoff N; Baumunk D; Hausmann D; Martini T; Marx A; Porubsky S; Schostak M; Michel MS; Ritter M
    Urol Oncol; 2018 Sep; 36(9):401.e1-401.e9. PubMed ID: 30093211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MRI-TRUS fusion guided prostate biopsy - initial experience and assessment of the role of contralateral lobe systematic biopsy.
    Andras I; Crisan D; Cata E; Tamas-Szora A; Caraiani C; Coman RT; Bungardean C; Mirescu C; Coman I; Crisan N
    Med Ultrason; 2019 Feb; 21(1):37-44. PubMed ID: 30779829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complications and Adverse Events of Three Magnetic Resonance Imaging-based Target Biopsy Techniques in the Diagnosis of Prostate Cancer Among Men with Prior Negative Biopsies: Results from the FUTURE Trial, a Multicentre Randomised Controlled Trial.
    Wegelin O; Exterkate L; van der Leest M; Kelder JC; Bosch JLHR; Barentsz JO; Somford DM; van Melick HHE
    Eur Urol Oncol; 2019 Nov; 2(6):617-624. PubMed ID: 31519516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.